Platelet count and risk of venous thromboembolism

Our findings suggest that platelet count may play a role in the pathogenesis of cancer-related venous thromboembolism.

In a large population based cohort study, including 26 160 subjects, we found that subjects with a high pre-cancer platelet count (≥295 x 109/L) had a 2-fold increased risk of future cancer related venous thromboembolism compared with subjects with low platelet count.

High platelet count did not influence the risk of venous thromboembolism in cancer-free subjects.


The article was published in PLOS one

 

References: Jensvoll H, Blix K, Braekkan SK, Hansen JB. Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromso Study. PloS one. 2014; 9: e92011.



Page administrator: Helle Jørgensen
Last updated: 24.06.2014 10:22
Skip to main content